Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Public Health. 2016 Apr 29;138:101–107. doi: 10.1016/j.puhe.2016.03.033

Table 2. Clinical characteristics of patientsφ.

Characteristic Only EPTB n=46 (%) Some form of PTB n=117(%) p-value
Initial Symptoms*
Cough 14 (30.4) 72 (61.5) <0.001
Lymphadenopathy 14 (30.4) 8 (6.8) <0.001
Weight loss 13 (28.3) 56 (47.9) 0.023
Fever 13 (28.3) 43 (36.8) 0.304
Chest pain 7 (15.2) 24 (20.5) 0.438
Anorexia 6 (13.0) 22 (18.8) 0.380
Night sweats 5 (10.9) 46 (39.3) <0.001
Altered mental status 5 (10.9) 5 (4.3) 0.114
Back pain 3 (6.5) 1 (0.9) 0.035
Shortness of breath 3 (6.5) 5 (4.3) 0.550
Malaise 2 (4.3) 9 (7.7) 0.444
Hemoptysis 1 (2.2) 9 (7.7) 0.186
GI symptoms 5 (10.9) 7 (6.0) 0.282
EPTB disease site
Lymph Node 14 (30.4)
Pleural 11 (23.9)
Bone 9 (19.6)
CNS TB 7 (15.2)
GI 4 (8.7)
Other 1 (2.2)
Diagnosis**
Microbiologic 32 (69.6) 94 (80.3) 0.126
Pathologic 4 (8.7) 1 (0.9) 0.022
Clinical 10 (21.7) 22 (18.8) 0.672

PTB = pulmonary tuberculosis; EPTB = extrapulmonary tuberculosis; CNS=central nervous system; GI=gastrointestinal

φ

Pearson's χ squared tests used for all analyses

*

Analysis of clinical symptoms of some form of EPTB vs. only PTB: some form of EPTB vs. only PTB less likely to have cough (25/64 [39.1%] vs. 61/99 [61.6%]; p=0.005) and hemoptysis (1/64 [1.6%] vs. 9/99 [9%]; p=0.05). Some form of EPTB more likely to have lymphadenopathy than only PTB (18/64 [28.1%] vs. 4/99 [4%]; p<0.001) and GI symptoms (10/64 [15.6%] vs. 2/99 [2%]; p=0.001). No other differences found.

EPTB disease sites for EPTB/PTB were as follows (n): lymph node (6), pleural (6), bone (1), CNS TB (1), GI (1), miliary (3)

**

More persons with EPTB/PTB had microbiological diagnosis than only PTB or EPTB (17/18 [94.4%] for EPTB/PTB; 77/99 [77.8%] for only PTB; 32/46 [69.6%] for only EPTB), but was not significant (p=0.158). More persons with only EPTB had pathologic diagnosis than only PTB or PTB/EPTB (4/46 [8.7%] for EPTB only; 1/99 for PTB only [1.0%]; 0/18 [0.0%] for EPTB/PTB); was not significant (p=.053). No difference in clinical diagnosis among only PTB, only EPTB, and EPTB/PTB (21/99 [21.2%]; 10/46 [21.7%]; 1/18 [5.6%], respectively; p=.028).